journal article·2020

Polydopamine-assisted one-step modification of nanofiber surfaces with adenosine to tune the osteogenic differentiation of mesenchymal stem cells and the maturation of osteoclasts

Taufiq Ahmad, Hayeon Byun, Hyeok Jun Shin, Jinkyu Lee, Sajeesh Kumar Madhurakkat Perikamana, Eun Mi Kim, Young Min Shin, Heungsoo Shin

Biomaterials Science· Volume 8· Issue 10
Publisher page

Abstract

Adenosine and its receptors have emerged as alternative targets to control cellular functions for bone healing. However, the soluble delivery of adenosine has not proven effective because of its fast degradation in vivo. We therefore designed a stable coating of adenosine for biomaterial surfaces through polydopamine chemistry to control osteogenesis and osteoclastogenesis via A2bR signaling. First, we prepared electrospun poly (ι-lactic acid) (PLLA) nanofiber sheets, which were modified through a one-step adenosine polydopamine coating process. Scanning electron microscopy (SEM) revealed deposition of particles on the adenosine polydopamine-coated PLLA (AP-PL) sheets compared to the polydopamine-only sheets. Moreover, X-ray photoelectron spectroscopy analysis confirmed an increase in nitrogen signals due to adenosine. Furthermore, adenosine loading efficiency and retention were significantly enhanced in AP-PL sheets compared to polydopamine-only sheets. Human adipose-derived stem cells (hADSCs) cultured on AP-PL expressed A2bR (1.30 ± 0.19 fold) at significantly higher levels than those cultured on polydopamine-only sheets. This in turn significantly elevated the expression of Runx2 (16.94 ± 1.68 and 51.69 ± 0.07 fold), OPN (1.63 ± 0.16 and 30.56 ± 0.25 fold), OCN (1.16 ± 0.13 and 5.23 ± 0.16 fold), and OSX (10.01 ± 0.81 and 62.48 ± 0.25 fold) in cells grown in growth media on days 14 and 21, respectively. Similarly, mineral deposition was enhanced to a greater extent in the AP-PL group than the polydopamine group, while blocking of A2bR significantly downregulated osteogenesis. Finally, osteoclast differentiation of RAW 264.7 cells was significantly inhibited by growth on AP-PL sheets. However, osteoclast differentiation was significantly stimulated after A2bR was blocked. Taken together, we propose that polydopamine-assisted one-step coating of adenosine is a viable method for surface modification of biomaterials to control osteogenic differentiation of stem cells and bone healing.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · RNA Interference and Gene Delivery · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering

Hanyang University

Seongdong-gu

Republic of Korea

BK21 Plus Future Biopharmaceutical Human Resources Training and Research Team

Funding

National Research Foundation of Korea

References (65)

Show source-provided references
1. Lopez · Adv. Drug Delivery Rev. · 2019 · 146 · 24010.1016/j.addr.2018.06.010 ↗
2. Layland · JACC Cardiovasc. Interv. · 2014 · 7 · 58110.1016/j.jcin.2014.02.009 ↗
3. Vallon · Physiol. Rev. · 2006 · 86 · 90110.1152/physrev.00031.2005 ↗
4. Eltzschig · J. Mol. Med. · 2013 · 91 · 14110.1007/s00109-013-0999-z ↗
5. Cronstein · Nat. Rev. Rheumatol. · 2017 · 13 · 4110.1038/nrrheum.2016.178 ↗
6. Mediero · Trends Endocrinol. Metab. · 2013 · 24 · 29010.1016/j.tem.2013.02.001 ↗
7. Kara · FASEB J. · 2010 · 24 · 232510.1096/fj.09-147447 ↗
8. He · Purinergic Signal. · 2012 · 8 · 32710.1007/s11302-012-9292-9 ↗
9. Carroll · J. Biol. Chem. · 2012 · 287 · 1571810.1074/jbc.M112.344994 ↗
10. Gharibi · Int. J. Obes. · 2012 · 36 · 39710.1038/ijo.2011.129 ↗
11. Corciulo · Purinergic Signal. · 2016 · 12 · 53710.1007/s11302-016-9519-2 ↗
12. He · FASEB J. · 2013 · 27 · 344610.1096/fj.13-231233 ↗
13. Costa · J. Cell. Physiol. · 2011 · 226 · 135310.1002/jcp.22458 ↗
14. Oh · Biomed. Sci. Lett. · 2017 · 23 · 19410.15616/BSL.2017.23.3.194 ↗
15. Kang · Sci. Adv. · 2016 · 2 · e160069110.1126/sciadv.1600691 ↗
16. Trincavelli · Biochim. Biophys. Acta, Mol. Cell Res. · 2014 · 1843 · 295710.1016/j.bbamcr.2014.09.013 ↗
17. Kazemzadeh-Narbat · J. Drug Targeting · 2015 · 23 · 58010.3109/1061186X.2015.1058803 ↗
18. Gomes · Neurochem. Res. · 2004 · 29 · 44110.1023/B:NERE.0000013749.65266.a2 ↗
19. Kang · Langmuir · 2012 · 28 · 1456210.1021/la303271f ↗
20. Kim · Biomaterials · 2005 · 26 · 277510.1016/j.biomaterials.2004.07.044 ↗
21. Kang · Biomaterials · 2017 · 149 · 1210.1016/j.biomaterials.2017.09.035 ↗
22. Mediero · FASEB J. · 2015 · 29 · 157710.1096/fj.14-265066 ↗
23. Mediero · FASEB J. · 2016 · 30 · 388710.1096/fj.201600616R ↗
24. Wang · Am. J. Physiol.: Gastrointest. Liver Physiol. · 2004 · 287 · G1100
25. Thimm · Biochemistry · 2013 · 52 · 72610.1021/bi3012065 ↗
26. Ahmad · Acta Biomater. · 2018 · 74 · 46410.1016/j.actbio.2018.05.035 ↗
27. Kang · Biomacromolecules · 2015 · 16 · 105010.1021/acs.biomac.5b00099 ↗
28. Sun · Int. J. Nanomed. · 2018 · 13 · 79110.2147/IJN.S152698 ↗
29. Shin · Tissue Eng., Part A · 2017 · 23 · 116910.1089/ten.tea.2016.0556 ↗
30. Luong · Biomaterials · 2012 · 33 · 28310.1016/j.biomaterials.2011.09.052 ↗
31. Wang · Mater. Today · 2013 · 16 · 22910.1016/j.mattod.2013.06.005 ↗
32. Madhurakkat Perikamana · ACS Appl. Mater. Interfaces · 2015 · 7 · 879810.1021/acsami.5b01340 ↗
33. Chen · Theranostics · 2017 · 7 · 107210.7150/thno.18193 ↗
34. Yoshinari · Biomed. Res. · 2006 · 27 · 2910.2220/biomedres.27.29 ↗
35. Madhurakkat Perikamana · Biomaterials · 2018 · 165 · 7910.1016/j.biomaterials.2018.02.046 ↗
36. Kang · Adv. Funct. Mater. · 2012 · 22 · 294910.1002/adfm.201200177 ↗
37. Madhurakkat Perikamana · Biomacromolecules · 2015 · 16 · 254110.1021/acs.biomac.5b00852 ↗
38. Nijhuis · Tissue Eng., Part C · 2013 · 19 · 61010.1089/ten.tec.2012.0313 ↗
39. Chien · ACS Appl. Mater. Interfaces · 2013 · 5 · 697510.1021/am401071f ↗
40. Mao · J. Am. Chem. Soc. · 2003 · 125 · 1421610.1021/ja036096p ↗
41. Piirainen · Biochim. Biophys. Acta, Biomembr. · 2011 · 1808 · 123310.1016/j.bbamem.2010.05.021 ↗
42. Ryu · ACS Appl. Mater. Interfaces · 2018 · 10 · 752310.1021/acsami.7b19865 ↗
43. Cho · ACS Appl. Mater. Interfaces · 2014 · 6 · 1122510.1021/am501391z ↗
44. Ahmad · Acta Biomater. · 2017 · 64 · 16110.1016/j.actbio.2017.10.022 ↗
45. Mu · Analyst · 2014 · 139 · 9310.1039/C3AN01592K ↗
46. Ding · Biosurf Biotribol · 2016 · 2 · 12110.1016/j.bsbt.2016.11.001 ↗
47. Azevedo · Adv. Drug Delivery Rev. · 2015 · 94 · 6310.1016/j.addr.2015.08.003 ↗
48. Lynge · Nanoscale · 2011 · 3 · 491610.1039/c1nr10969c ↗
49. Fan · Soft Matter · 2015 · 11 · 462110.1039/C5SM00732A ↗
50. Kang · Angew. Chem., Int. Ed. · 2010 · 49 · 940110.1002/anie.201004693 ↗
51. Lebon · Nature · 2011 · 474 · 52110.1038/nature10136 ↗
52. G. Vattay and I.Csabai
53. Mao · J. Mol. Biol. · 2004 · 336 · 78710.1016/j.jmb.2003.12.056 ↗
54. Ahmad · J. Ind. Eng. Chem. · 2018 · 67 · 8010.1016/j.jiec.2018.06.017 ↗
55. Sitaraman · J. Biol. Chem. · 2002 · 277 · 3318810.1074/jbc.M202522200 ↗
56. Evans · Front. Endocrinol. · 2012 · 3 · 1
57. Hamidzadeh · Front. Immunol. · 2016 · 7 · 110.3389/fimmu.2016.00074 ↗
58. Teramachi · Lab. Invest. · 2011 · 91 · 71910.1038/labinvest.2011.9 ↗
59. Li · ACS Appl. Mater. Interfaces · 2014 · 6 · 940210.1021/am5017792 ↗
60. Lee · Macromol. Biosci. · 2010 · 10 · 17310.1002/mabi.200900169 ↗
61. Lee · Biomaterials · 2013 · 34 · 505910.1016/j.biomaterials.2013.03.051 ↗
62. Shih · Proc. Natl. Acad. Sci. U. S. A. · 2014 · 111 · 99010.1073/pnas.1321717111 ↗
63. Schell · Bone · 2006 · 38 · 54710.1016/j.bone.2005.09.018 ↗
64. Madhurakkat Perikamana · Macromol. Biosci. · 2019 · 19 · e180039210.1002/mabi.201800392 ↗
65. Grimaud · Am. J. Pathol. · 2003 · 163 · 202110.1016/S0002-9440(10)63560-2 ↗